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We have studied the effects of the H3-receptor agonist (R)a-methylhistamine
[(R)a-MeHA] and the H3-receptor antagonist thioperamide (Thiop) on basal-
andcarbachol-stimulated vasculargastrin release (GR) and somatostatin release
(SR) by the isolated rat stomach. Carbachol dose-dependently stimulated and
inhibited GR and SR, respectively. Maximal stimulation ofGR (500 + 112 per-
cent of basal; p < .01), and maximal inhibition of SR (-62 + 9 percent under
basal; p < .01) were obtained with 1 jM carbachol. Neither (R)a-MeHA nor
Thiop, up to 10 gM, affected GR. However, SR was dose-dependently
enhanced by Thiop (25 + 8 percent for 10 gM). Carbachol stimulation of GR
was strongly inhibited by Thiop (30 + 7 percent for 100 nM and 73 + 14 per-
cent for 1 gM), whereas it was potentiated by (R)ax-MeHA. Carbachol inhibi-
tion ofSRwas reversedbyThiop and(R)a-MeHA. However, thereversal effect
of (R)a-MeHA was prevented by the CCKB/gastrin receptor antagonist
PD134308. These results support H3-receptor regulation ofbasal and choliner-
gically-stimulated GR and SR.
INTRODUCTION
The groundwork for histamine H3-receptor was laid by Arrang et al. [1] who report-
ed that histamine inhibits its own release and synthesis in rat brain histaminergic nerves
endings. Because this effect was not blocked by H1- or H2-receptor antagonists, it was
attributed to a novel receptor sub-type [1, 2]. Investigations on the H3-receptor have now
broadened, and it is becoming recognized as a multifunctional receptor with widespread
location. Indeed, this receptor sub-type is not restricted to histaminergic neurons since it
has been demonstrated on perivascular nerves [3, 4] and on sertoninergic, noradrenergic,
non-adrenergic, cholinergic and non-cholinergic neurones [5, 6, 7, 8, 9, 10]. Furthermore,
it has also been suggested to occur in the skin [11] and the lung [6, 7].
The presence of a H3-receptor in the gastric mucosa is supported by a body of evi-
dence. We previously reported (R)a-methylhistamine [(R)a-MeHA]b inhibition ofpenta-
gastrin- and meal-stimulated gastric acid secretion in the gastric fistula cat [12], while oth-
ers reported (R)a-MeHA inhibition of central cholinergic stimulation ofacid secretion in
the fistula dog [13]. Furthermore, we provided evidence for (R)ax-MeHA inhibition of
basal and gastrin-stimulated vascular histamine release in the perfused rat stomach [14].
In addition, we showed that thioperamide (Thiop) enhanced, whereas (R)a-MeHA inhib-
ited, basal histamine release by the isolated rabbit gastric glands [15]. These findings led
us to propose the presence of an H3-receptor on the enterochromaffin-like (ECL) cells.
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This view was recently confirmed by observations suggesting H3-receptor regulation of
gastrin-induced histamine release from isolated rat ECL cells [16].
In the isolated rabbit gastric glands, Thiop-induced histamine release was paralleled
with a stimulation of 14C-aminopyrine uptake. However, this stimulation was unsensitive
to the H2 receptor antagonist ranitidine. Moreover, we found that (R)a-MeHA inhibited,
whereas thioperamide enhanced, both histamine- and carbachol-induced 14C-aminopyrine
uptake in a ranitidine-unsensitive manner [15]. Since histamine and carbachol act direct-
ly on the parietal cell, the latter effects would involve post-receptor interactions and fur-
ther suggest that, in addition to the ECLcell, the parietal cell would also be endowed with
a H3-receptor. However, a direct evidence for a parietal cell H3-receptor is still lacking.
In contrast to histamine, (R)a-MeHA does not enhance intracellular cAMP produc-
tion (except in millimolar concentrations) on isolated human gastric glands [17], neither
does itinhibit histamine stimulated cAMPproduction (personal observation). Such obser-
vations make it unlikely that cAMP is involved in H3-receptor signalling. In accord with
this, we recently reported that (R)a-MeHA concentration-dependently inhibits basal- and
carbachol-stimulated formation ofphosphaditylinositides (InsP)InsP,, InsP2 and InsP3 in
the human gastric cell line HGT1 [18]. The H3-receptor of the HGT1 cells has been fur-
ther purified as a 67kDa protein [18], but so far, its associated G protein[s] has not been
identified.
Clearly, the above findings support that H3-receptor regulation of acid secretion
might involve receptors located on different cell types. To further investigate this aspect,
the present study addresses the effects of (R)a-MeHA and Thiop on basal and carbachol-
stimulated vascular releases of somatostatin and gastrin by the isolated rat stomach. The
current findings provide pharmacological evidence supporting the occurrence of an addi-
tional H3 or H3-like receptor located on the somatostatin or the gastrin cell or both.
MATERIALAND METHODS
Animals and surgery
Male Wistar rats (R. Janvier, Le Genest, France) weighing 250-400 g were used in
these experiments. The animals were deprived of solid food overnight but allowed water
ad libitum. Anesthesia was induced by 20 percent urethane injected intraperitoneally, and
1000 IU heparin sodium was subcutaneously injected 15 min before laparotomy. The
stomach was isolated and vascularly perfused as previously described [19]. The prepara-
tion was maintained at 37°C throughout the experiments by a thermostatically controlled
heating block. The entire surgical procedure was completed in 45 min, and the period of
ischemia starting with ligation ofthe aorta above the celiac axis did not exceed one min.
Experimentalprocedures
The lumen of the stomach was perfused at a rate of 1 ml/min with saline buffered at
pH 7.4 with 20 mM NaHCO3. The vasculature ofthe stomach was isolated and perfused
at a rate of 2 ml/min with Krebs-buffer solution containing four percent dextran (Sigma
Chemicals Co, StLouis, Missouri, USA) and two percent bovine serum albumin (Fraction
V, Sigma Chemicals). The composition ofthe Krebs solution was: NaCl, 80 mM; KCI, 5
mM; MgCl2 1.5 mM; CaCl2 1 mM; NaH2PO4 0.5 mM; Na2HPO4 1 mM; NaHCO3 20
mM; Glucose, 4.5 mM; and aprotinin, 100 UI/ml. The perfusion was continuously gassed
with 95 percent 02-5 percent CO2 to maintain a pH of 7.4. Samples of vascular effluent
was collected every two-min interval and stored at -20°C for subsequent gastrin and
somatostatin radioassays. At the end ofeachexperiment, the intactness ofthe vascular bed
was challenged by injecting phenol red through the perfusion catheter, and those experi-
ments in which phenol red was detected in the lumen were discarded. Furthermore, theBado et al.: H3-receptor regulation ofgastrin and somatostatin 'is
functional viability of the isolated stomach was assessed by showing the persistence of
carbachol stimulation ofgastrin release three hours after the begining ofthe experiments,
whereas these never overstep 90 min.
The experimental design after surgery and the 30-min equilibration were as follows:
a) a 10-min-control sampling period; b) a 30-min drug infusion period; and c) a 10-min
period after cessation of drug infusion. In dose-response studies, one concentration of
drugs was infused for each stomach during period b. In four experiments, no drug was
infused, and basal secretion of the peptides was determined for 50-min periods to assess
the spontaneous release of gastrin and somatostatin. The effect of H3-receptor was
assessed by infusing (R)a-MeHA or Thiop either alone or together with carbachol. In
another set ofexperiments, theCCKB/gastrin-receptor antagonist PD134308 [20, 21] was
infused together with (R)a-MeHA and carbachol.
Radioimmunoassays ofgastrin and somatostatin
Gastrin immunoassay was run in duplicate using 125I-Gastrin-17 as a tracer
(Amersham, England). The rabbit gastrin antiserum used recognized the C-terminus ofall
matured forms of gastrin. Cross-reactivities with CCK4 was less than 0.001 percent and
less than two percent with CCK8 and CCK33. Separation of free and bound tracer was
achieved using a mixture ofcharcoal and Dextran. Detection limit was 0.1 pg/ml of stan-
dard Human gastrin-17.
Somatostatin was assayed in duplicate as described in detail elsewhere [22]. Briefly,
the antibody raised in sheep (gift from P. Brazeau, Montreal) recognized both somato-
statin-14 and somatostatin-28 and was used at a final dilution of 1/60,000; 1251-Tyrl-
somatostatin was used as a tracer with an assay sensitivity of 10 pg/tube. Tyrl-somato-
statin-14 (Sigma chemicals, St-Louis Missouri, USA) was iodinated according to the
chloramine T method [23] and purified by chromatography on a carboxymethyl cellulose
(CM52) column. Somatostatin concentrations for each sample were determined using
somatostatin-14 as standard. Synthetic somatostatin-14 orgastrin-17 was added to the per-
fusate and the serial dilution of the sample produced a curve parallelling that ofthe stan-
dard curves for somatostatin and gastrin.
DATA EXPRESSION AND STATISTICALANALYSIS
Basal gastrin release (GR) and somatostatin release (SR) varied from stomach to
stomach but maintained during the 50-min observation periods. The mean gastrin con-
centrations in portal effluent during the drugs infusion period were calculated and
Table 1. Summary ofthe effects ofthe H -receptor agonist and antagonist, respectively, (R)a-
MeHA and Thioperamide, ongastrin and somatostatin releases from the isolated perfused rat
stomach. Results are the means of + SEM ofthe average values from 10 to 20 min (i.e., periods of
the infusion of H3 ligands) and are expressed as percentage change above or below basal.
Somatostatin Gastrin
Basal
Thioperamide 1 IM +20 + 4% -12 + 8%
(R)a-MeHA -10 + 6% +2 + 8%
Stimulated
Carbachol 1 ,uM -63 + 2% +380 + 34%
+ (R)a-MeHA 1 jM -34 + 11% +996 + 93%
+ Thioperamide 100 nm -22 + 8% +214 + 30%
+Thioperamide IjM +15 + 3% +71 + 15%Bado et al.: H3-receptor regulation ofgastrin andsomatostatin
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Figure 1. Dose-response curves for carbachol, H3-receptor agonist (R)cx-MeHA or antagonist
thioperamide on gastrin (A) and somatostatin (B release from the isolated perfused rat stom-
ach. Results areexpressed inpicograms/min. Values are means + 1 SEM ofsix toeightexperiments.
(p < .05 vs control)
expressed as apercentage ofbasal secretion (10-mi period). Somatostatin secretion (gen-
erally adecrease) was evaluated in the same manner, and the data were expressed as aper-
centage ofdecrease under basal secretion. The data were analyzed by Student's t-test for
paired values, and p < .05 was considered significant.
RESULTS
Dose-response effects ofcarbachol, [R]a-MeHA and Thioperamide on gastrin and
somatostatin reeeases
Carbachol dose-dependently stimulated GR from the perfused rat stomach. Half-
maximal and maximal responses were achieved for 20 nM and 10 RM, respectively
(Figure 1A). (R)a-MeHA at concentrations ranging from 1 nM to 10 RiM were without
any effect by its own on basal GR, whereas Thiop slightly, but non-significantly, reduced
this release (Table I).
Carbachol dose-dependently inhibited SR. Half-maximal and maximal effects were
achieved for 30 nM and 10gim, respectively. (R)a-MeHA had no effect on basal SR, up
to 10 jiM. However, Thiop dose-dependently increased basal SR with a maximal effect
reaching 25 ± 8 percent for 10 jiM. (Figure IB).
Effects of[R]a-MeHA and Thiop on carbachol-inducedgastrin and somatostatin
releases
Carbachol produced a rapid and time-dependent basal GR increase, levelling offdur-
ing the infusion at 500 + 112 percent of basal (p < .01 vs. control). GR returned to con-
trol level on cessation of carbachol infusion. Thiop dose-dependently inhibited carbachol
stimulation ofgastrin release by 30±+7 percent and 73±+ 14 percent (p < .01I vs. carbachol
alone) for 100 nM and 1 jiM , respectively. On cessation ofThiop infusion, GR returned
to control (Figure 2).
Carbachol time-dependently decreased basal SR. This decrease was significant as
soon as four min after the start ofthe infusion, and maximal inhibition reached 62 + 9 per-
cent under basal (p < .01). However, carbachol inhibition was totally blocked by 100 nM
116Bado et al.: H3-receptor regulation ofgastrin and somatostatin
FIGURE 2 * Carbachol alone
Thiop
0 Carb.+ Thiop 1OOnM
Th o A Carb.+Thiop 1pM
Carbachol 1 pM c
co
Cu ' ' cs<+25-
Cc
/E~~~~~~~~~~cBad
-0-
E -75 0
10 20 30 40 CD Time (min)
FIGURE 3
~I I I i''-
-
-10 0 10 20 30 40
Time (min)
Figure 2. Effect of H3-receptor antagonist thioperamide on carbachol-stimulated gastrin
release from the isolated perfused rat stomach. Results are expressed as a percentage of basal.
Values are means + 1 SEM of six to eight experiments. (p < .05 vs. carbachol alone).
Figure3. Effect ofH3-receptorantagonist thioperamide on the carbachol inhibition ofsomato-
statin release by the isolated perfused rat stomach. Results are expressed as a percentage under
basal. Values are means + 1 SEM of six to eight experiments (p < .05 vs. carbachol alone).
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Figure 4. Effect ofH -receptor agonist (R)a-MeHAalone or in combination with thioperamide
on carbachol-stimulated gastrin release by the isolated perfused rat stomach. Results are
expressed as a percentage over basal. Values are means + 1 SEM of six to eight experiments.
(p < .05 vs. carbachol alone).
Figure 5. Effect of H3-receptor agonist (R)a-MeHA on the carbachol inhibition of somato-
statin release by the isolated perfused rat stomach. Results are expressed as a percentage under
basal. Values are means + 1 SEM of six to eight experiments. (p < .05 vs. carbachol alone)
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Thiop. This blockade effect occurred within the first four min and lasted for the whole
duration ofThiop infusion. Interestingly, 1 ,uM Thiop not only reverted carbachol inhibi-
tion but also produced a significant stimulation of SR (Figure 3).
Addition of 1 jiM (R)a-MeHA to carbachol resulted in a further increase in GR. The
effect was rapid (within the first two min ofthe infusion) and maintained for a while after
the end of infusion. It corresponded to a potentiation since the effect of (R)a-MeHA
together with carbachol was higher than the summation of the effect of each drug alone.
Furthermore, it was H3-receptor specific since it was completely abolished by the addition
of 1 ,uM thioperamide (Figure 4).
On the other hand, (R)a-MeHA reversed carbachol-induced inhibition ofSR (Figure
5). To evaluate whether this reversal effect could be secondary to increased GR, we
repeated the experiment in the presence of the CCKB/gastrin receptor antagonist
PD134308. As shown in Figure 6, PD134308 did not affect the effect of (R)a-MeHA on
carbachol-induced GR. However, it suppressed the effect of(R)a-MeHA on SR and com-
pletely restored carbachol inhibition of SR, producing even a further decrease of this
release as compared to carbachol alone.
DISCUSSION
The putative role of histamine as a regulator of gastric releases of somatostatin and
gastrin is still an open question. Using the perfused rat stomach model, two different
groups have reported evidence for histamine stimulation ofSR [24, 25, 26]. This stimula-
tion was increased by micromolar concentrations ofcimetidine which, on the other hand,
blocked cholinergic inhibition of SR [26, 27]. However, a lack of effect of H2-receptor
blockade on basal SR has also been reported [24].
S 1200
Ca .0
FIGURE 6 1-0* vsCarbachol alone
0 O~ .. vsCarbachol+ Ra-MeHA
400
CU 0 T [] + +CARBACHOLpM
C#O 0 0 +P1330Ip
Co~-
coC.O4
C60
CU
Figure 6. Effect of H3-receptor agonist (R)a-MeHA alone or in combination with the
CCKB/Gastrin receptor antagonist PD134308 on the carbachol stimulation of gastrin and
inhibition ofsomatostatin releases by the isolated rat perfused stomach. Values are means + 1
SEM ofeight experiments, and results areexpressed as apercentage ofbasal (gastrin) orunderbasal
(somatostatin).
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The present findings showing Thiop enhancement of basal SR are consistent with
previous reports from our and other laboratories on isolated rabbit gastric glands [15] and
isolated mouse stomachs [25]. As far as the fundic part ofthe stomach is concerned, they
could be explained by Thiop stimulation ofhistamine release due to inhibition H3-recep-
tors on the ECL cells [15, 16] and histamine inhibition of SR through a putative D-cell
receptor.
Under our experimental conditions, with the lumen of the isolated stomach being
maintained at pH 7, we clearly found that carbachol inhibited SR and stimulated GR in
the absence of any feed back due to acid secretion. This is in agreement with previous
studies [19, 28, 29, 30]. In our study, (R)a-MeHA fails to affect basal gastrin release. We
have no explanation forthis, butit is likely that itreflects the level ofendogenous-released
histamine or that the whole stomach preparation is not adequate to demonstrate such an
effect. However, we found that (R)a-MeHA produced a dramatic potentiation of carba-
chol stimulation of GR, which is consistent with preliminary observations [28, 31];
whereasThiop bothprevented carbachol inhibition ofSR and carbachol stimulation ofGR
(Table 1). These observations cannot be unequivocally explained with the experimental
model used. First, it is not known, whether the effects ofcarbachol on GR and SR are due
to direct interactions with the somatostatin and the gastrin cells or are indirectly exerted.
For instance, these effects could be secondary to histamine release from the ECL cells or
mediated by intrinsic neurons. Second, since the gastrin cell is equipped with an inhibito-
ry somatostatin receptor and the somatostatin cell with a stimulatory gastrin receptor [32,
33, 34], SR and GR are interacting each other. Taking this into consideration, a simple
hypothesis is that the effects of the H3 ligands on SR are just the consequence of those
produced on GR. Consistent with this view is the observation that the paradoxical effect
produced by (R)a-MeHA on carbachol inhibition of SR, i.e., an apparent reversal of this
inhibition in spite of the large increase observed for GR (Figure 6), is prevented by the
CCKB/gastrin receptor antagonist PD134308.
In conclusion, the present study provides a new insight into H3-receptor regulation of
gastric functions. In addition to the H3-receptor, which has been pharmacologically
described on the ECL cell [16, 35] and to that suggestively present on the parietal cell
[15], it appears that H3 or H3-resembling receptors may be also involved in cholinergic
regulation ofgastrin and somatostatin secretions. However, whether these putative recep-
tors are located on the gastrin and/or somatostatin cells or are beared by other cell types,
e.g., intrinsic neurons, remains to be elucidated.
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